Sabra Health Care REIT, Inc. (SBRA)
NASDAQ: SBRA · Real-Time Price · USD
20.67
-0.23 (-1.09%)
At close: May 15, 2026, 4:00 PM EDT
20.52
-0.15 (-0.73%)
After-hours: May 15, 2026, 7:35 PM EDT

Sabra Health Care REIT Statistics

Total Valuation

SBRA has a market cap or net worth of $5.21 billion. The enterprise value is $7.76 billion.

Market Cap5.21B
Enterprise Value 7.76B

Important Dates

The last earnings date was Wednesday, April 29, 2026, after market close.

Earnings Date Apr 29, 2026
Ex-Dividend Date May 15, 2026

Share Statistics

SBRA has 252.19 million shares outstanding. The number of shares has increased by 4.47% in one year.

Current Share Class 252.19M
Shares Outstanding 252.19M
Shares Change (YoY) +4.47%
Shares Change (QoQ) +1.26%
Owned by Insiders (%) 1.28%
Owned by Institutions (%) 104.44%
Float 248.90M

Valuation Ratios

The trailing PE ratio is 32.79 and the forward PE ratio is 29.84. SBRA's PEG ratio is 3.59.

Price/FFO Ratio 13.85
Price/AFFO Ratio n/a
PE Ratio 32.79
Forward PE 29.84
PS Ratio 6.39
Forward PS 5.89
PB Ratio 1.87
P/TBV Ratio 1.92
P/FCF Ratio n/a
P/OCF Ratio 14.21
PEG Ratio 3.59
Financial Ratio History

Enterprise Valuation

EV / Earnings 49.69
EV / Sales 9.51
EV / EBITDA 16.90
EV / EBIT 29.02
EV / FCF n/a

Financial Position

The company has a current ratio of 2.62, with a Debt / Equity ratio of 0.96.

Current Ratio 2.62
Quick Ratio 1.99
Debt / Equity 0.96
Debt / EBITDA 5.81
Debt / FCF n/a
Interest Coverage 2.77

Financial Efficiency

Return on equity (ROE) is 5.68% and return on invested capital (ROIC) is 4.88%.

Return on Equity (ROE) 5.68%
Return on Assets (ROA) 3.09%
Return on Invested Capital (ROIC) 4.88%
Return on Capital Employed (ROCE) 4.88%
Weighted Average Cost of Capital (WACC) 6.40%
Revenue Per Employee $14.06M
Profits Per Employee $2.69M
Employee Count58
Asset Turnover 0.15
Inventory Turnover n/a

Taxes

In the past 12 months, SBRA has paid $1.95 million in taxes.

Income Tax 1.95M
Effective Tax Rate 1.23%

Stock Price Statistics

The stock price has increased by +18.11% in the last 52 weeks. The beta is 0.65, so SBRA's price volatility has been lower than the market average.

Beta (5Y) 0.65
52-Week Price Change +18.11%
50-Day Moving Average 20.30
200-Day Moving Average 19.25
Relative Strength Index (RSI) 53.09
Average Volume (20 Days) 2,309,836

Short Selling Information

The latest short interest is 28.99 million, so 11.49% of the outstanding shares have been sold short.

Short Interest 28.99M
Short Previous Month 27.78M
Short % of Shares Out 11.49%
Short % of Float 11.65%
Short Ratio (days to cover) 13.52

Income Statement

In the last 12 months, SBRA had revenue of $815.66 million and earned $156.19 million in profits. Earnings per share was $0.63.

Revenue815.66M
Gross Profit 519.94M
Operating Income 267.46M
Pretax Income 157.97M
Net Income 156.19M
EBITDA 459.21M
EBIT 267.46M
Earnings Per Share (EPS) $0.63
Full Income Statement

Balance Sheet

The company has $124.18 million in cash and $2.67 billion in debt, with a net cash position of -$2.55 billion or -$10.10 per share.

Cash & Cash Equivalents 124.18M
Total Debt 2.67B
Net Cash -2.55B
Net Cash Per Share -$10.10
Equity (Book Value) 2.79B
Book Value Per Share 11.05
Working Capital 183.49M
Full Balance Sheet

Cash Flow

Operating Cash Flow 366.71M
Capital Expenditures n/a
Depreciation & Amortization 196.63M
Net Borrowing n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 63.74%, with operating and profit margins of 32.79% and 19.15%.

Gross Margin 63.74%
Operating Margin 32.79%
Pretax Margin 19.37%
Profit Margin 19.15%
EBITDA Margin 56.30%
EBIT Margin 32.79%
FCF Margin n/a

Dividends & Yields

This stock pays an annual dividend of $1.20, which amounts to a dividend yield of 5.81%.

Dividend Per Share $1.20
Dividend Yield 5.81%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 190.38%
Buyback Yield -4.47%
Shareholder Yield 1.33%
Earnings Yield 3.00%
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for SBRA is $22.25, which is 7.64% higher than the current price. The consensus rating is "Buy".

Price Target $22.25
Price Target Difference 7.64%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (5Y) 12.09%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6